| Industry | Status | Date | Ticker(s) | issuer(s) | MO | SP | FI | Size (M) | Ranking | TNR | Call | MTY | Coupon | Leads | product | Region | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLTH | PRCD | Nov 19, 2019 | TEVA | Teva Pharmaceutical Finance Netherlands III BV | Ba2 | BB | - | $1,000 | Sr. Unsecured | 5.00 | - | Jan-25 | 7.125% | HYC | EMEA | ||||
HLTH | PRCD | Nov 8, 2018 | TEVA | Allergan Inc | Baa3 | BBB | - | €700 | Sr. Unsecured | 2.00 | - | Nov-20 | 3mEu+35 | IGC | USOA | ||||
HLTH | PRCD | Nov 8, 2018 | TEVA | Allergan Inc | Baa3 | BBB | - | €500 | Sr. Unsecured | 5.00 | - | Nov-23 | 1.50% | IGC | USOA | ||||
HLTH | PRCD | Nov 8, 2018 | TEVA | Allergan Inc | Baa3 | BBB | - | €500 | Sr. Unsecured | 10.00 | - | Nov-28 | 2.625% | IGC | USOA | ||||
HLTH | PRCD | Mar 6, 2018 | TEVA | Teva Pharmaceutical Finance Netherlands III BV | Ba2 | BB | - | €700 | Senior | 4.00 | - | Apr-22 | 3.25% | HYC | EMEA | ||||
HLTH | PRCD | Mar 6, 2018 | TEVA | Teva Pharmaceutical Finance Netherlands III BV | Ba2 | BB | - | $1,250 | Senior | 6.00 | - | Apr-24 | 6.00% | HYC | EMEA | ||||
HLTH | PRCD | Mar 6, 2018 | TEVA | Teva Pharmaceutical Finance Netherlands III BV | Ba2 | BB | - | €900 | Senior | 7.00 | - | Mar-25 | 4.50% | HYC | EMEA | ||||
HLTH | PRCD | Mar 6, 2018 | TEVA | Teva Pharmaceutical Finance Netherlands III BV | Ba2 | BB | - | $1,250 | Senior | 10.00 | - | Mar-28 | 6.75% | HYC | EMEA | ||||
HLTH | PRCD | May 23, 2017 | TEVA | Allergan Inc | Baa3 | BBB | - | €700 | Sr. Unsecured | 2.00 | - | Jun-19 | 3mE+35 | IGC | USOA | ||||
HLTH | PRCD | May 23, 2017 | TEVA | Allergan Inc | Baa3 | BBB | - | €750 | Sr. Unsecured | 4.00 | - | Jun-21 | 0.5% | IGC | USOA |